Generated Narrative: StructureDefinition ext-R4-MedicinalProductPharmaceutical Name Flags Card. Type Description & Constraints Extension 0..* Extension(4.3.0) A pharmaceutical product described in terms of its composition and dose form #xD; Slices for extension 2..* Extension Extension Slice: Unordered, Closed by value:url #xD; extension:administrableDoseForm 1..1 Extension The administrable dose form, after necessary reconstitution #xD; url 1..1 uri "administrableDoseForm" #xD; value[x] 0..1 CodeableConcept The administrable dose form, after necessary reconstitution #xD; extension:unitOfPresentation 0..1 Extension Todo #xD; url 1..1 uri "unitOfPresentation" #xD; value[x] 0..1 CodeableConcept Todo #xD; extension:ingredient 0..* Extension Ingredient #xD; url 1..1 uri "ingredient" #xD; value[x] 0..1 Reference() Ingredient #xD; extension:device 0..* Extension Accompanying device #xD; url 1..1 uri "device" #xD; value[x] 0..1 Reference() Accompanying device #xD; extension:characteristics 0..* Extension Characteristics e.g. a products onset of action #xD; Slices for extension 1..* Extension Extension Slice: Unordered, Closed by value:url #xD; extension:code 1..1 Extension A coded characteristic #xD; url 1..1 uri "code" #xD; value[x] 0..1 CodeableConcept A coded characteristic #xD; extension:status 0..1 Extension The status of characteristic e.g. assigned or pending #xD; url 1..1 uri "status" #xD; value[x] 0..1 CodeableConcept The status of characteristic e.g. assigned or pending #xD; url 1..1 uri "characteristics" #xD; extension:routeOfAdministration 1..* Extension The path by which the pharmaceutical product is taken into or makes contact with the body #xD; Slices for extension 1..* Extension Extension Slice: Unordered, Closed by value:url #xD; extension:code 1..1 Extension Coded expression for the route #xD; url 1..1 uri "code" #xD; value[x] 0..1 CodeableConcept Coded expression for the route #xD; extension:firstDose 0..1 Extension The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement #xD; url 1..1 uri "firstDose" #xD; value[x] 0..1 Quantity The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement #xD; extension:maxSingleDose 0..1 Extension The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement #xD; url 1..1 uri "maxSingleDose" #xD; value[x] 0..1 Quantity The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement #xD; extension:maxDosePerDay 0..1 Extension The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation #xD; url 1..1 uri "maxDosePerDay" #xD; value[x] 0..1 Quantity The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:maxDosePerTreatmentPeriod" title="Slice maxDosePerTreatmentPeriod: This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.maxDosePerTreatmentPeriod from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">extension:maxDosePerTreatmentPeriod 0..1 Extension The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation #xD; url 1..1 uri "maxDosePerTreatmentPeriod" #xD; value[x] 0..1 Ratio The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:maxTreatmentPeriod" title="Slice maxTreatmentPeriod: This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">extension:maxTreatmentPeriod 0..1 Extension The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation #xD; url 1..1 uri "maxTreatmentPeriod" #xD; value[x] 0..1 Duration The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation #xD; extension:targetSpecies 0..* Extension A species for which this route applies #xD; Slices for extension 1..* Extension Extension Slice: Unordered, Closed by value:url #xD; extension:code 1..1 Extension Coded expression for the species #xD; url 1..1 uri "code" #xD; value[x] 0..1 CodeableConcept Coded expression for the species #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod" title="Slice withdrawalPeriod: This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">extension:withdrawalPeriod 0..* Extension A species specific time during which consumption of animal product is not appropriate #xD; Slices for extension 2..* Extension Extension Slice: Unordered, Closed by value:url #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod.extension:tissue" title="Slice tissue: This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">extension:tissue 1..1 Extension Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk #xD; url 1..1 uri "tissue" #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod.extension:tissue.value[x]" title="This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">value[x] 0..1 CodeableConcept Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod.extension:value" title="Slice value: This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.value from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">extension:value 1..1 Extension A value for the time #xD; url 1..1 uri "value" #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod.extension:value.value[x]" title="This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.value from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">value[x] 0..1 Quantity A value for the time #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod.extension:supportingInformation" title="Slice supportingInformation: This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">extension:supportingInformation 0..1 Extension Extra information about the withdrawal period #xD; url 1..1 uri "supportingInformation" #xD; <a href="StructureDefinition-ext-R4-MedicinalProductPharmaceutical-definitions.html#Extension.extension:routeOfAdministration.extension:targetSpecies.extension:withdrawalPeriod.extension:supportingInformation.value[x]" title="This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.">value[x] 0..1 string Extra information about the withdrawal period #xD; url 1..1 uri "withdrawalPeriod" #xD; url 1..1 uri "targetSpecies" #xD; url 1..1 uri "routeOfAdministration" #xD; url 1..1 uri "http://hl7.org/fhir/4.0/StructureDefinition/extension-MedicinalProductPharmaceutical" #xD; Documentation for this format
Cross-version Extension for R4.MedicinalProductPharmaceutical for use in FHIR R4B
This cross-version extension represents MedicinalProductPharmaceutical from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
A pharmaceutical product described in terms of its composition and dose form
All FHIR elements must have a @value or children unless an empty Parameters resource
hasValue() or (children().count() > id.count()) or $this is Parameters
Must have either extensions or value[x], not both
exists(f:extension)!=exists(f:*[starts-with(local-name(.), 'value')])
Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.
Extensions are always sliced by (at least) url
All FHIR elements must have a @value or children
hasValue() or (children().count() > id.count())
exists(f:extension)!=exists(f:*[starts-with(local-name(.), "value")])
The administrable dose form, after necessary reconstitution
This cross-version extension represents MedicinalProductPharmaceutical.administrableDoseForm from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
Additional content defined by implementations
May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.
There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.
Source of the definition for the extension code - a logical name or a URL.
The definition may point directly to a computable or human-readable definition of the extensibility codes, or it may be a logical URI as declared in some other specification. The definition SHALL be a URI for the Structure Definition defining the extension.
This cross-version extension represents MedicinalProductPharmaceutical.unitOfPresentation from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.ingredient from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.device from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
Characteristics e.g. a products onset of action
This cross-version extension represents MedicinalProductPharmaceutical.characteristics from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.characteristics.code from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
The status of characteristic e.g. assigned or pending
This cross-version extension represents MedicinalProductPharmaceutical.characteristics.status from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
Value of extension - must be one of a constrained set of the data types (see [Extensibility](http://hl7.org/fhir/R4B/extensibility.html) for a list).
The path by which the pharmaceutical product is taken into or makes contact with the body
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.code from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.firstDose from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.maxSingleDose from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.maxDosePerDay from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.maxDosePerTreatmentPeriod from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.maxTreatmentPeriod from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.code from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
A species specific time during which consumption of animal product is not appropriate
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.value from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.
Extra information about the withdrawal period
This cross-version extension represents MedicinalProductPharmaceutical.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation from http://hl7.org/fhir/StructureDefinition/MedicinalProductPharmaceutical|4.0.1 for use in FHIR R4B.